Drug-induced bullous pemphigoid: Cases triggered by intravenous iodine and etanercept

Clinical and Experimental Dermatology

Volumn 36, Issue 8, 2011, Pages 871-873

  Kluk, J ^a   Goulding, J M R ^a   Bhat, J ^a   Finch, T M ^a  

^a SOLIHULL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BASEMENT MEMBRANE ANTIBODY; COMPLEMENT COMPONENT C3; CORTICOSTEROID; ETANERCEPT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IOPAMIDOL; IOVERSOL; PREDNISOLONE; USTEKINUMAB;

ADULT; ANGIOCARDIOGRAPHY; ANTIBODY DETECTION; ARTHROPATHY; ARTICLE; BLISTER; BULLOUS PEMPHIGOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EOSINOPHIL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS; REMISSION; SKIN BIOPSY; SKIN EXAMINATION; SKIN PRURITUS; TREATMENT OUTCOME; TREATMENT RESPONSE; URTICARIA;

ANTI-INFECTIVE AGENTS, LOCAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; IODINE; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 81255168241     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04102.x     Document Type: Article

References (10)

1. Wojnarowska F, Venning VA, Burge SM,. Subepidermal immunobullous diseases. In: Rook's Textbook of Dermatology, 7th edn (, Burns T, Breathnach S, Cox N, Griffiths C, eds). Oxford: Blackwell Publishing, 2004; 41.33.
2. Bastuji-Garin S, Joly P, Picard-Dahan C, et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 1996; 132: 272-6. (Pubitemid 26085178)
3. Lloyd-Lavery A, Taghipour K, Wojnarowska FT,. A case-control study demonstrating drug associations in patients diagnosed with bullous pemphigoid. Br J Dermatol 2010; 163 (Suppl. 1): 28.
4. Piletta P, Rieckhoff L, Saurat JH,. Triggering of bullous pemphigoid by iodine. Br J Dermatol 1994; 131: 145-7.
5. Bordignon M, Belloni-Fortina A, Pigozzi B, et al. Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology 2009; 219: 357-8.
6. Daulat S, Detweiler JG, Pandya AG,. Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept. J Eur Acad Dermatol Venereol 2009; 23: 483-4.
7. Wilczek A, Sticherling M,. Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship? Int J Dermatol 2006; 45: 1353-7. (Pubitemid 44688036)
8. Ludwig RJ, Schmidt E,. Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis? G Ital Dermatol Venereol 2009; 144: 339-49.
9. Yamauchi PS, Lowe NJ, Gindi V,. Treatment of coexisting bullous pemphigoid and psoriasis with the tumour necrosis factor antagonist etanercept. J Am Acad Dermatol 2006; 54 (Suppl. 2): S121-2. (Pubitemid 43243484)
10. Strausbol-Gron B, Deleuran M, Sommer Hansen E, Kragballe K,. Development of bullous pemphigoid during treatment of psoriasis with adalimumab. Clin Exp Dermatol 2009; 34: e285-6.